LC-MS/MS identification of the one-carbon cycle metabolites in human plasma

The one‐carbon cycle is composed of four major biologically important molecules: methionine (l‐Met), S‐adenosylmethionine (SAM), S‐adenosylhomocysteine (SAH), and homocysteine (Hcy). In addition to these key metabolites, there are multiple enzymes, vitamins, and cofactors that play essential roles i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Electrophoresis 2013-06, Vol.34 (11), p.1710-1716
Hauptverfasser: Gardner, Lidia A., Desiderio, Dominic M., Groover, Chassidy J., Hartzes, Anastasia, Yates, Charles R., Zucker-Levin, Audrey R., Bloom, Leonard, Levin, Michael C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The one‐carbon cycle is composed of four major biologically important molecules: methionine (l‐Met), S‐adenosylmethionine (SAM), S‐adenosylhomocysteine (SAH), and homocysteine (Hcy). In addition to these key metabolites, there are multiple enzymes, vitamins, and cofactors that play essential roles in the cascade of the biochemical reactions that convert one metabolite into another in the cycle. Simultaneous quantitative measurement of four major metabolites can be used to detect possible aberrations in this vital cycle. Abnormalities in the one‐carbon cycle might lead to hyper‐ or hypomethylation, homocystinemia, liver dysfunction, and accumulation of white‐matter hyperintensities in the human brain. Previously published methods describe evaluation of several components of the one‐carbon cycle, but none to our knowledge demonstrated simultaneous measurement of all four key molecules (l‐Met, SAM, SAH, and Hcy). We describe a novel analytical method suitable for simultaneous identification and quantification of l‐Met, SAM, SAH, and Hcy with LC‐MS/MS. Moreover, we tested this method to identify these metabolites in human plasma collected from patients with multiple sclerosis and healthy individuals. In a pilot feasibility study, our results indicate that patients with multiple sclerosis showed abnormalities in the one‐carbon cycle.
ISSN:0173-0835
1522-2683
DOI:10.1002/elps.201200536